Entegris, Inc. — Q2 2022 Form 10-Q
Reporting period: Quarter ended July 2, 2022; unaudited results compare with the quarter ended July 3, 2021. Entegris supplies advanced materials and process solutions for semiconductor and other high-technology industries. Its segments are Specialty Chemicals and Engineered Materials (SCEM), Microcontamination Control (MC), and Advanced Materials Handling (AMH).
Financial performance
| Metric | Q2 2022 | Q2 2021 | Six months 2022 | Six months 2021 |
|---|---|---|---|---|
| Net sales | $692.5m | $571.4m | $1,342.1m | $1,084.2m |
| Gross margin | 44.8% | 46.4% | 46.2% | 46.2% |
| Operating income | $158.0m | $138.9m | $321.3m | $252.9m |
| Net income | $99.5m | $88.8m | $225.2m | $173.4m |
| Diluted EPS | $0.73 | $0.65 | $1.65 | $1.27 |
| Operating cash flow | — | $174.7m | $135.0m | |
| Capital expenditures | — | $192.1m | $85.1m |
Q2 sales rose 21%, driven mainly by volume growth; unfavorable currency translation reduced sales by $20.3m. Gross margin declined 1.6 percentage points, reflecting currency effects and higher excess and obsolete inventory costs, partly offset by volume. For the first half, sales increased 24% and gross margin was unchanged year over year. Net income margin was 14.4% in Q2 versus 15.5%; for the first half it was 16.8% versus 16.0%.
All three segments grew in Q2: SCEM sales increased 15% to $207.7m, MC sales increased 20% to $274.1m, and AMH sales increased 30% to $224.1m. Segment profits were $45.7m, $100.1m, and $46.9m, respectively. MC had the largest segment-profit increase, up 28%.
First-half operating cash flow improved by $39.7m, but inventory and receivables absorbed cash amid increased activity and safety-stock needs. Investing used $191.0m, principally for property and equipment, leaving operating cash flow less property and equipment purchases at approximately negative $17.4m. Financing provided $2.37bn, primarily from debt issued in connection with the pending CMC acquisition.
Liquidity, debt, and material developments
- At July 2, cash and cash equivalents were $253.0m, with an additional $2.49bn of restricted cash held in escrow for the CMC Materials acquisition and unavailable for general corporate use. Total reported cash, cash equivalents, and restricted cash was $2.74bn.
- Debt at July 2 was $3.41bn net of discounts and issuance costs ($3.45bn par). This included $1.6bn of 4.75% secured notes due 2029 and $895m of 5.95% unsecured notes due 2030, issued to finance the acquisition. The company reported compliance with debt covenants at quarter-end.
- On July 6, after quarter-end, Entegris completed its approximately $5.7bn acquisition of CMC Materials. Consideration included $3.8bn cash paid to shareholders, 12.9m Entegris shares, approximately $0.9bn of CMC debt retired, and approximately $200m of acquired cash. Acquisition financing included a $2.495bn term loan, a $275m bridge loan, and an expanded $575m revolving facility. The company reported approximately $6.1bn of total debt as of July 6.
- Management said available liquidity and anticipated operating cash flows should meet ordinary-course needs for the next 12 months and longer term. A July 28 interest-rate swap hedges SOFR exposure on $1.95bn of the term loan through December 2025. The board declared a $0.10-per-share quarterly dividend; the company suspended share repurchases and did not anticipate a new program in 2022.
Outlook, commentary, and risks
The filing provides no numerical forward guidance. Management described strong demand, including for leading-edge products, supported by digitalization, 5G, and high-performance computing. It also cited supply-chain and logistics disruption, raw-material constraints, higher freight and material costs, labor constraints, and inflation. The company said it had adequate supplies of materials sourced from Russia and Ukraine, but noted uncertainty about the conflict’s effects on supply chains and costs.
Key risks include the substantial post-acquisition debt burden, interest-rate exposure, the ability to integrate CMC and realize expected synergies, customer and supplier retention, semiconductor-market cyclicality, foreign-exchange volatility, and reliance on sole- or limited-source suppliers. The company also identified potential covenant restrictions and the risk that future cash flow or capital-market access may be insufficient to service debt or meet other needs. It said ordinary-course legal matters were not expected to have a material adverse effect. Disclosure controls were judged effective; no material change in internal control over financial reporting was reported.
Important facts for investors to verify
- Post-close debt, interest expense, leverage, covenant headroom, and the effect of the term-loan interest-rate swap.
- Integration costs, purchase-price allocation, and evidence that CMC delivers anticipated synergies and benefits.
- Whether demand growth and margins persist as currency headwinds, inflation, inventory costs, and supply constraints evolve.
- Cash generation and capital spending after the acquisition; distinguish unrestricted cash from acquisition escrow funds.
- Future dividend policy and management’s decision not to resume share repurchases in 2022.